Clinical trials

  • ENCOBERMINOGENE REZMADENOVEC for Refractory angina pectoris | Coronary artery disease
  • CLDN6 CAR-T for Solid tumors | Non-small cell lung cancer | Ovarian cancer | Uterine cancer | Gastric cancer | Testicular cancer | Carcinoma of unknown primary
  • Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the alpha-L-iduronidase cDNA for Mucopolysaccharidosis type I (Hurler syndrome)
  • KYV-101 for Rheumatoid arthritis
  • DAPAGLIFLOZIN for Aortic stenosis
  • DALBAVANCIN for Catheter-related bloodstream infection due to Staphylococcus aureus
  • DSIMC for End-stage liver disease | Liver transplantation
  • RUCAPARIB for Ovarian epithelial cancer | Primary peritoneal carcinoma (malignant peritoneal neoplasm) | Fallopian tube cancer | Advanced high-grade epithelial ovarian/fallopian tube/primary peritoneal cancer
  • Bevacizumab for Glioblastoma
  • Human IgG1 hexavalent antibody against TNFRSF4 for Head and neck squamous cell carcinoma
  • ANAKINRA for Inflammatory dilated cardiomyopathy
  • EPINEPHRINE for Cardiorespiratory arrest at birth